Russell Investments Group
MXCT icon

Russell Investments Group’s MaxCyte MXCT Stock Holding History

Russell Investments Group’s Portfolio MXCT Stock Details MXCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$5.88K Sell
8,376
-630
-7% -$588 ﹤0.01% 3870
2025
Q4 		$14K Sell
9,006
-478
-5% -$764 ﹤0.01% 3716
2025
Q3 		$15K Buy
+9,484
New +$16.5K ﹤0.01% 3681
2024
Q2 		– Sell
-6,700
Closed -$28.1K – 3611
2024
Q1 		$28.1K Buy
+6,700
New +$31.5K ﹤0.01% 2736
2023
Q2 		– Sell
-33,155
Closed -$164K – 3504
2023
Q1 		$164K Buy
+33,155
New +$163K ﹤0.01% 2509

Other funds holding MXCT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CFM
Capricorn Fund Managers London, United Kingdom $1.27B AUM 70.17% 1-Year Est. Return
VP
Vitruvian Partners London, United Kingdom $112M AUM 2.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
MA
Mudita Advisors London, United Kingdom $490M AUM 66.64% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $86.1B AUM 29.11% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BFM
Brooklands Fund Management London, United Kingdom $88.9M AUM

Russell Investments Group's MXCT Position: Q1 2026 in Review

Russell Investments Group reduced its MaxCyte (MXCT) stake by 7% in Q1 2026, selling an estimated $588 and leaving 8,376 shares worth $5.88K. The position accounts for ﹤0.01% of the portfolio, ranked #3870.

Russell Investments Group first reported a position in MXCT in Q1 2023 and has held it in 5 quarters since. The position peaked at $164K in Q1 2023. 130 funds tracked by Wall St. Rank hold MXCT as of Q1 2026.

  • Russell Investments Group held 8,376 shares of MaxCyte worth $5.88K as of Q1 2026.
  • Russell Investments Group sold 630 MaxCyte shares in Q1 2026, an estimated $588.
  • MaxCyte made up ﹤0.01% of Russell Investments Group's portfolio in Q1 2026, its #3870 holding.
  • Russell Investments Group first reported a position in MaxCyte in Q1 2023 and has held it in 5 quarters since.
  • Russell Investments Group's MaxCyte position peaked at $164K in Q1 2023.
  • 130 funds tracked by Wall St. Rank held MaxCyte as of Q1 2026.

Based on Russell Investments Group's 13F filing for Q1 2026, filed 8 May 2026.